×
About 4,448 results

ALLMedicine™ Allergic Asthma Center

Research & Reviews  1,628 results

Ganoderma Modulates Allergic Asthma Pathologic Features via Anti-inflammatory Effects.
https://doi.org/10.1016/j.resp.2022.103843
Respiratory Physiology & Neurobiology; Li Y, Li M et. al.

Jan 14th, 2022 - Ganoderma, a fungal genus, is a traditional medicine with immuno-modulating effects. Asthma is an inflammatory disease of airways, and the main trigger of asthma is allergic inflammation. In this study, the effects of Ganoderma (an anti-inflammato...

Cryptococcus neoformans in Association with Dermatophagoides pteronyssinus has Pro- (IL...
https://doi.org/10.1007/s10753-021-01619-4 10.3390/jof4010033 10.1016/j.clindermatol.2012.01.005 10.3389/fcimb.2020.00037 10.1007/s12016-018-8693-0 10.1111/j.1462-5822.2012.01757.x 10.1093/mmy/myv024 10.1016/j.ejphar.2017.03.029 10.1016/j.freeradbiomed.2013.11.028 10.1155/2015/178369 10.1128/cdli.2.6.753-759.1995 10.1111/imm.13195 10.1016/j.vetimm.2008.04.020 10.1165/rcmb.2014-0102OC 10.1016/j.vaccine.2019.10.051 10.1111/j.1440-1843.2009.01539.x 10.1016/j.it.2011.06.006 10.1007/s00430-021-00715-4 10.1186/s12929-016-0247-2.PMID:26897523;PMCID:PMC4761181 10.1016/j.ejmech.2017.03.046 10.1128/EC.00054-14 10.1016/j.mib.2016.07.018 10.1165/ajrcmb.12.4.7695916 10.1016/j.jaci.2018.05.026 10.1080/14728222.2020.1744567 10.1007/s00109-015-1325-8 10.1007/s12038-014-9496-y 10.1016/j.bbamcr.2011.01.034 10.1111/j.1462-5822.2012.01819.x 10.7150/ijbs.4874 10.1093/mmy/myy086 10.1128/IAI.65.3.931-935.1997 10.1089/jir.2013.0149 10.1002/art.20058 10.1371/journal.pone.0025083 10.4049/jimmunol.1400334 10.1016/j.jaci.2008.02.004 10.1096/fj.11-196477 10.1016/j.cyto.2008.03.010 10.1159/000430375 10.4049/jimmunol.177.10.6842 10.1074/jbc.M116.738187 10.1007/s12026-015-8730-5 10.1111/imm.12938
Inflammation Souza HI, Pereira ABM et. al.

Jan 12th, 2022 - Cryptococcosis (caused, for example, by Cryptococcus neoformans) and allergic asthma (caused, for example, by Dermatophagoides pteronyssinus) target the respiratory tract (the lung and bronchial epithelium). C. neoformans and D. pteronyssinus can ...

Exacerbation of allergic asthma by somatic antigen of Echinococcus granulosus in allerg...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734303
Parasites & Vectors; Ghabdian S, Parande Shirvan S et. al.

Jan 8th, 2022 - There is ample evidence demonstrating a reverse relationship between helminth infection and immune-mediated diseases. Accordingly, several studies have shown that Echinococcus granulosus infection and hydatid cyst compounds are able to suppress im...

Severe pediatric asthma with a poor response to omalizumab: a report of three cases and...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743945
The Journal of International Medical Research; Tsuge M, Ikeda M et. al.

Jan 8th, 2022 - Omalizumab is used for the treatment of persistent severe allergic asthma in adults and children. However, some patients remain symptomatic even after omalizumab treatment. In bronchial asthma, chronic inflammation of the bronchial wall causes thi...

Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic Disease
https://clinicaltrials.gov/ct2/show/NCT05177744

Jan 5th, 2022 - This study will involve schoolchildren (aged 6-18 years), population cohort based on differential exposure and susceptibility to allergy(paediatric population, allergic vs. healthy subjects). participants will be selected based on proven sensitiza...

see more →

Guidelines  3 results

EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma.
https://doi.org/10.1111/all.13749
Allergy Agache I, Lau S et. al.

May 17th, 2019 - Allergen immunotherapy (AIT) has been in use for the treatment of allergic disease for more than 100 years. Asthma treatment relies mainly on corticosteroids and other controllers recommended to achieve and maintain asthma control, prevent exacerb...

Asthma management: A new phenotype-based approach using presence of eosinophilia and al...
https://doi.org/10.1111/all.13165
Allergy Terl M, Sedlák V et. al.

Mar 23rd, 2017 - Asthma is a heterogeneous disease. The Czech Pneumology and Allergology Societies commissioned 10 experts to review the literature and create joint national guidelines for managing asthma, reflecting this heterogeneity. The aim was to develop an e...

Recommendations for the standardization of clinical outcomes used in allergen immunothe...
https://doi.org/10.1111/all.12383
Allergy Pfaar O, Demoly P et. al.

Apr 26th, 2014 - Allergen immunotherapy (AIT) has been thoroughly documented in randomized controlled trials (RCTs). It is the only immune-modifying and causal treatment available for patients suffering from IgE-mediated diseases such as allergic rhinoconjunctivit...

see more →

Drugs  12 results see all →

Clinicaltrials.gov  56 results

Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic Disease
https://clinicaltrials.gov/ct2/show/NCT05177744

Jan 5th, 2022 - This study will involve schoolchildren (aged 6-18 years), population cohort based on differential exposure and susceptibility to allergy(paediatric population, allergic vs. healthy subjects). participants will be selected based on proven sensitiza...

XOLAIR (Omalizumab) Outcomes in Pediatric Allergic Asthma Patients in the United States
https://clinicaltrials.gov/ct2/show/NCT05157087

Dec 16th, 2021 - This was a retrospective database pre-post cohort study, identifying asthmatic patients with omalizumab use over 24 months. Omalizumab use was analyzed in two categories. First, initiators were defined as individuals with ≥ 1 omalizumab claims. "R...

Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma
https://clinicaltrials.gov/ct2/show/NCT00232999

Nov 12th, 2021 - This study is designed to evaluate the effectiveness of nebulized IVX-0142, a novel anti-allergic drug, to inhibit allergen-induced airway narrowing in patients with allergic asthma and the related increased sensitivity of the airways to other sub...

Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.
https://clinicaltrials.gov/ct2/show/NCT03468790

Oct 11th, 2021 - Approximately 400 asthma patients with an increased serum total IgE level(60-1500 international unit(IU)/ml) and uncontrolled receiving medium to high dose inhaled corticosteroid (ICS) plus long-acting β2-agonist(LABA) will be randomised in about ...

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
https://clinicaltrials.gov/ct2/show/NCT04195958

Sep 16th, 2021 - This study will assess the effect of omalizumab on exercise capacity, physical activity, and sleep quality after 24 weeks of treatment in participants with moderate to severe allergic asthma. Exercise capacity will be assessed using cardiopulmonar...

see more →

News  80 results

Impact of Allergic Rhinitis and Asthma on COVID-19
https://www.medscape.com/viewarticle/962799

Nov 11th, 2021 - Takeaway Allergic rhinitis (AR; in all ages) and allergic or non-allergic asthma (in those aged <65 years) were associated with a lower risk of COVID-19 infection, but not with the severity and mortality of COVID-19. Asthma was linked to an increa...

Tezepelumab Reduces Asthma Exacerbation Rates by 56%
https://www.medscape.com/viewarticle/954777

Jul 14th, 2021 - The US Food and Drug Administration (FDA) has granted priority review for the biologic tezepelumab (AstraZeneca/Amgen) for treatment of severe asthma. The announcement was reported July 8, just days before the start of the European Academy of Alle...

Fast Five Quiz: Allergic Asthma Management
https://reference.medscape.com/viewarticle/916463

May 14th, 2021 - Allergic asthma is an increasingly prevalent chronic respiratory disease that imposes a significant burden on individuals, resulting in substantial healthcare costs, impairments to quality of life, and increased morbidity and mortality. The World ...

Fast Five Quiz: Allergic Asthma Management
https://www.medscape.com/viewarticle/916463

May 14th, 2021 - Allergic asthma is an increasingly prevalent chronic respiratory disease that imposes a significant burden on individuals, resulting in substantial healthcare costs, impairments to quality of life, and increased morbidity and mortality. The World ...

Asthma-COPD Overlap Linked to Occupational Pollutants
https://www.medscape.com/viewarticle/947124

Mar 9th, 2021 - The development and worsening of overlapping asthma and chronic obstructive pulmonary disease (COPD) can be affected by pollutants found in rural and urban environments, according to a recent presentation at the annual meeting of the American Acad...

see more →